Clinical implications of the mechanism o
β
John Marshall
π
Article
π
2006
π
John Wiley and Sons
π
English
β 189 KB
π 2 views
## Abstract Novel therapeutic agents that target the epidermal growth factor receptor (EGFR) constitute an important addition to the therapeutic armamentarium for the treatment of metastatic disease. EGFRβtargeted agents currently approved by the U.S. Food and Drug Administration include cetuximab,